SCHEMBL7216840

SCHEMBL7216840

Cc1ccc(-c2cccn2-c2ccc(S(N)(=O)=O)cc2)nc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 14/20 0.61
PTGS1 P23219 5/20 0.52
CA1 P00915 4/20 0.43
CA2 P00918 4/20 0.43
CA9 Q16790 3/20 0.43
CYP2C9 P11712 1/20 0.43
CA5A P35218 3/20 0.42
CA5B Q9Y2D0 3/20 0.42
CA12 O43570 2/20 0.42
CA3 P07451 1/20 0.42
CA6 P23280 1/20 0.42
CA7 P43166 1/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7210547 0.88 PTGS2 (0.60) PTGS2PTGS1
SCHEMBL7216997 0.82 PTGS2 (0.58) PTGS2PTGS1CA1CA2CA9
SCHEMBL7210295 0.80 PTGS2 (0.56) PTGS2PTGS1CA1CA2CA9
SCHEMBL5308822 0.80 PTGS2 (0.74) PTGS2PTGS1CA1CA2CA9
SCHEMBL5315090 0.80 PTGS2 (0.74) PTGS2PTGS1CA1CA2CA9
SCHEMBL8505620 0.79 PTGS2 (0.41) PTGS2CA1CA2CA9CA12
SCHEMBL7212078 0.76 PTGS2 (0.58) PTGS2PTGS1CA1CA2CA9
SCHEMBL5594798 0.76 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL7210594 0.75 PTGS2 (0.59) PTGS2PTGS1CA1CA2CA9
SCHEMBL7210726 0.74 PTGS2 (0.60) PTGS2PTGS1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1369415-A1 Substituted pyrrolyl compounds for the treatment of inflammation G.D. SEARLE & CO. (US) 2003-12-10 EP claimed
EP-1369415-A1 Substituted pyrrolyl compounds for the treatment of inflammation G.D. SEARLE & CO. (US) 2003-12-10 EP disclosed